A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia

被引:73
作者
Ostedgaard, LS
Rokhlina, T
Karp, PH
Lashmit, P
Afione, S
Schmidt, M
Zabner, J
Stinski, MF
Chiorini, JA
Welsh, MJ
机构
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA
[4] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA
[5] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA
关键词
CMV; promoter; gene therapy;
D O I
10.1073/pnas.0409845102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Adeno-associated viruses (AAVs) such as AAV5 that transduce airway epithelia from the apical surface are attractive vectors for gene transfer in cystic fibrosis (CF). However, their utility in CF has been limited because packaging of the insert becomes inefficient when its length exceeds approximate to4,900-5,000 bp. To partially circumvent this size constraint, we previously developed a CIF transmembrane conductance regulator (CFTR) transgene that deleted a portion of the R domain (CFTRDeltaR). In this study, we focused on shortening the other elements in the AAV expression cassette. We found that portions of the CMV immediate/early (CMVie) enhancer/promoter could be deleted without abolishing activity. We also tested various intervening sequences, poly(A) signals, and an intron to develop an expression cassette that meets the size restrictions imposed by AAV. We then packaged these shortened elements with the CFTRDeltaR transgene into AAV5 and applied them to the apical surface of differentiated CF airway epithelia. Two to 4 weeks later, the AAV5 vectors partially corrected the CF Cl- transport defect. These results demonstrate that a single AAV vector can complement the CF defect in differentiated airway epithelia and thereby further the development of effective CF gene transfer.
引用
收藏
页码:2952 / 2957
页数:6
相关论文
共 46 条
[1]   Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles [J].
Chiorini, JA ;
Yang, L ;
Liu, YJ ;
Safer, B ;
Kotin, RM .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6823-6833
[2]   Cloning and characterization of adeno-associated virus type 5 [J].
Chiorini, JA ;
Kim, F ;
Yang, L ;
Kotin, RM .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1309-1319
[3]   EXTENSIVE POSTTRANSCRIPTIONAL DELETION OF THE CODING SEQUENCES FOR PART OF NUCLEOTIDE-BINDING FOLD-1 IN RESPIRATORY EPITHELIAL MESSENGER-RNA TRANSCRIPTS OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE IS NOT ASSOCIATED WITH THE CLINICAL MANIFESTATIONS OF CYSTIC-FIBROSIS [J].
CHU, CS ;
TRAPNELL, BC ;
CURRISTIN, SM ;
CUTTING, GR ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :785-790
[4]   Recombinant adeno-associated virus vectors for gene therapy [J].
Conlon, TJ ;
Flotte, TR .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) :1093-1101
[5]   Gene therapy for cystic fibrosis [J].
Davies, JC ;
Geddes, DM ;
Alton, EWFW .
JOURNAL OF GENE MEDICINE, 2001, 3 (05) :409-417
[6]   Identification of PDGFR as a receptor for AAV-5 transduction [J].
Di Pasquale, G ;
Davidson, BL ;
Stein, CS ;
Martins, IS ;
Scudiero, D ;
Monks, A ;
Chiorini, JA .
NATURE MEDICINE, 2003, 9 (10) :1306-1312
[7]   Quantitative analysis of the packaging capacity of recombinant adeno-associated virus [J].
Dong, JY ;
Fan, PD ;
Frizzell, RA .
HUMAN GENE THERAPY, 1996, 7 (17) :2101-2112
[8]   Current status of gene therapy for inherited lung diseases [J].
Driskell, RA ;
Engelhardt, JE .
ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 :585-612
[9]  
Flotte TR, 1999, CURR OPIN MOL THER, V1, P510
[10]  
FLOTTE TR, 1993, J BIOL CHEM, V268, P3781